PLATINOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Platinol, and what generic alternatives are available?
Platinol is a drug marketed by Hq Spclt Pharma and is included in one NDA.
The generic ingredient in PLATINOL is cisplatin. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cisplatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Platinol
A generic version of PLATINOL was approved as cisplatin by PHARMACHEMIE BV on May 16th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLATINOL?
- What are the global sales for PLATINOL?
- What is Average Wholesale Price for PLATINOL?
Summary for PLATINOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 342 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PLATINOL at DailyMed |
![PLATINOL drug patent expirations Drug patent expirations by year for PLATINOL](/p/graph/s/t/PLATINOL-patent-expirations.png)
Recent Clinical Trials for PLATINOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Regeneron Pharmaceuticals | Phase 2 |
AstraZeneca | Phase 3 |
Wuhan Union Hospital, China | Phase 2 |
Pharmacology for PLATINOL
Drug Class | Platinum-based Drug |
US Patents and Regulatory Information for PLATINOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hq Spclt Pharma | PLATINOL | cisplatin | INJECTABLE;INJECTION | 018057-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hq Spclt Pharma | PLATINOL-AQ | cisplatin | INJECTABLE;INJECTION | 018057-003 | Jul 18, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PLATINOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hq Spclt Pharma | PLATINOL | cisplatin | INJECTABLE;INJECTION | 018057-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Hq Spclt Pharma | PLATINOL | cisplatin | INJECTABLE;INJECTION | 018057-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PLATINOL
See the table below for patents covering PLATINOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 362052 | ⤷ Sign Up | |
Japan | S619923 | ⤷ Sign Up | |
Japan | S54157817 | PHARMACEUTICAL PREPARED SOLUTION | ⤷ Sign Up |
South Africa | 7900395 | ⤷ Sign Up | |
German Democratic Republic | 142293 | VERFAHREN ZUR HERSTELLUNG EINES PHARMAZEUTISCHEN MITTELS | ⤷ Sign Up |
Finland | 66121 | ⤷ Sign Up | |
Sweden | 7900774 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |